poisar

Stocks · News reference

Elevance Health shares are trading higher after the company reaffirmed its FY26 GAAP and adjusted EPS guidance.

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ELV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Not Specified

    The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipient

    Dr. Aaron L. Schwartz, an assistant professor at the University of Pennsylvania, has been awarded the 2026 AJMC Seema S. Sonnad Emerging Leader in Managed Care Research Award for his groundbreaking work on low-value care metrics and prior authorization research. His claims-based measures have been adopted by CMS for accountable care programs, and his research has influenced policy decisions at major healthcare organizations and government agencies.

    HUMELV
  2. Na

    How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet

    Centene Corporation has significantly improved its financial position by generating nearly $8 billion in operating cash flow in the first half of 2026 and reducing its debt-to-capital ratio to 41.6% through $1.3 billion in senior note repurchases. The company monetized $1 billion in Part D receivables to support debt reduction while maintaining financial flexibility amid Medicaid payment timing swings.

    CNCMOHELV
  4. Zacks.Com

    Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth

    CVS Health's Health Services segment demonstrated strong Q2 2026 performance with revenues rising 11.5% to $51.8B and adjusted operating income climbing 10%. Health Care Delivery revenues jumped nearly 23% driven by Oak Street Health, while Pharmacy Services benefited from favorable drug mix and strong new sales of $6B. The company maintained its full-year 2026 outlook despite 340B program adjustments.

    CVSUNHELV